# A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis

> **NCT00601107** · PHASE2 · COMPLETED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 111 (actual)

## Conditions studied

- Moderate to Severe Chronic Plaque Psoriasis

## Interventions

- **DRUG:** Doxercalciferol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00601107
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-02
- **Final completion:** 2009-06
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2014-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00601107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00601107, "A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00601107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*